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Abstract
Background: Where malaria endemicity is low, control programmes need increasingly sensitive tools for
monitoring malaria transmission intensity (MTI) and to better define health priorities. A cross-sectional survey was
conducted in a low endemicity area of the Peruvian north-western coast to assess the MTI using both molecular
and serological tools.
Methods: Epidemiological, parasitological and serological data were collected from 2,667 individuals in three
settlements of Bellavista district, in May 2010. Parasite infection was detected using microscopy and polymerase
chain reaction (PCR). Antibodies to Plasmodium vivax merozoite surface protein-119 (PvMSP119) and to Plasmodium
falciparum glutamate-rich protein (PfGLURP) were detected by ELISA. Risk factors for exposure to malaria
(seropositivity) were assessed by multivariate survey logistic regression models. Age-specific antibody prevalence of
both P. falciparum and P. vivax were analysed using a previously published catalytic conversion model based on
maximum likelihood for generating seroconversion rates (SCR).
Results: The overall parasite prevalence by microscopy and PCR were extremely low: 0.3 and 0.9%, respectively for
P. vivax, and 0 and 0.04%, respectively for P. falciparum, while seroprevalence was much higher, 13.6% for P. vivax
and 9.8% for P. falciparum. Settlement, age and occupation as moto-taxi driver during previous year were
significantly associated with P. falciparum exposure, while age and distance to the water drain were associated with
P. vivax exposure. Likelihood ratio tests supported age seroprevalence curves with two SCR for both P. vivax and P.
falciparum indicating significant changes in the MTI over time. The SCR for PfGLURP was 19-fold lower after 2002 as
compared to before (λ1 = 0.022 versus λ2 = 0.431), and the SCR for PvMSP119 was four-fold higher after 2006 as
compared to before (λ1 = 0.024 versus λ2 = 0.006).
Conclusion: Combining molecular and serological tools considerably enhanced the capacity of detecting current
and past exposure to malaria infections and related risks factors in this very low endemicity area. This allowed for
an improved characterization of the current human reservoir of infections, largely hidden and heterogeneous, as
well as providing insights into recent changes in species specific MTIs. This approach will be of key importance for
evaluating and monitoring future malaria elimination strategies.
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Background
Despite recent reduction in its estimated incidence, ma-
laria remains the most important human arthropod-
borne disease, worldwide and in the Americas [1]. In
Peru, malaria incidence has fluctuated dramatically over
the last 50 years. Between 1954 and 1967, malaria was
well under control by coordinated eradication efforts
(resulting in only 1,500 cases in 1965) [2], but returned
to high levels when eradication campaigns ceased. Fol-
lowing the occurrence of drug-resistant Plasmodium
falciparum strains to chloroquine (CQ) and sulphadoxine-
pyrimethamine (SP) [3,4] and the spread of Anopheles
darlingi in the Amazon Region [5], malaria re-emerged
in the 1990s, reaching a peak of more than 200,000 cases
in 1998 after the El Niño Southern Oscillation (ENSO)
climatologic phenomenon [6]. Between 2000 and 2005,
the annual incidence fluctuated between 70,000 and
80,000 cases followed by a steady decrease until 2011,
when 22,877 cases were reported [7]. This achievement
can be attributed to the strengthening of the National
Malaria Control Programme (NMCP) and to the imple-
mentation of comprehensive interventions such as the
use of artemisinin-based combination therapy (ACT),
the distribution of long-lasting insecticidal mosquito
nets (LLINs), and health education campaigns with the
strong support of international donors, e g, US Agency
for International Development (USAID), and the Global
Fund for Aids, Tuberculosis and Malaria (GFATM)
[8-10].
In Peru, the significant decline in malaria incidence
over the past decade has modified its epidemiological
profile and consequently calls for adapted control stra-
tegies. Currently, there is the need for targeting inter-
ventions and surveillance to foci of residual transmission
in the north-west coast as well as in the Peruvian Ama-
zon region. A key element for this re-orientation will be
the availability of accurate measurement of malaria
transmission intensity (MTI) and its evolution in space
and time [11,12]. However, it is not clear how best to
monitor changes in transmission and disease burden in
low endemicity areas [13].
Traditional methods to measure MTI include the collec-
tion of entomological and parasitological parameters. How-
ever, in areas of low endemicity, these measures are often
subject to fluctuations for reasons other than true changes
in transmission. For example, the improvement of case de-
tection methods usually leads to an artificial increase in
malaria incidence, which makes difficult the comparison
between pre- and post-intervention data. Furthermore, en-
tomological (entomological inoculation rate (EIR)) and
parasitological measures (infections detected by micros-
copy) estimated through community surveys require very
large sample sizes and are therefore extremely time and
money consuming, while not able to catch seasonal
Figure 1 Study area in Bellavista district (Piura department, northwestern coast of Peru) including three settlements. Pavletich (PAV),
Jose Carlos Mariátegui (JCM) and Nuevo Porvenir (NP).
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variations [14,15]. Moreover, parasitological surveys using
microscopy cannot detect subpatent infections which are
commonly reported in areas of low transmission [16,17].
Molecular tests such as polymerase chain reaction (PCR)
are much more sensitive for the detection of low parasite-
density infections, and will become increasingly important
for malaria elimination programmes [18,19].
Serological markers have recently been used in several
endemic areas across the world to estimate MTI [20-24]
and monitor its changes over time following interven-
tions [25]. Serological techniques are particularly suited
to low endemic areas as antibodies remain in the blood
longer than malaria parasites and are thus easier to de-
tect and less subject to seasonal variations. This paper
reports on population-based estimates of P. falciparum
and Plasmodium vivax prevalence and seroprevalence in
an area of low endemicity in the north-west coast of
Peru. The combination of molecular and serological
tools is aimed at improving the detection of current mal-
aria infections as well as recent exposure, in order to get
insights into the residual transmission dynamics.
Methods
Study area
The study was conducted in Bellavista, a small district of
Sullana province located in Piura department, north-
western coast of Peru (Figure 1). Piura is historically
considered an important focus of malaria transmission
in Peru [26]. Bellavista district is a peri-urban settlement
(37,000 inhabitants in 2010) directly connected to
Sullana city, at 30 km from Piura, the fifth largest city in
Peru. Three contiguous squatter settlements were se-
lected for the study: Pavletich (PAV, nine blocks of
houses), Jose Carlos Mariátegui (JCM, 12 blocks) and
Nuevo Porvenir (NP, 13 blocks) based on their malaria
endemicity (between 2008 and 2010 most of the district
malaria cases occurred in these settlements) and their
proximity to the largest water drain called Boqueron
(=big hole). Situated at the eastern edge of the settle-
ments, this artificially created drain flows from south to
Table 1 Baseline characteristics of the study population
(N = 2,667)
n %
Settlement
Pavletich (PV) 1,128 42.3
José Carlos Mariategui (JCM) 797 29.9
Nuevo Porvenir (NP) 742 27.8
House distance to water drain (m)
<100 183 6.9
100–250 1401 52.5
>250 1,083 40.6
Gender
Female 1,628 61.0
Male 1,039 39.0
Age groups (years)
0–5 447 16.8
6–10 404 15.1
11–19 491 18.4
20–39 889 33.3
> = 40 436 16.4
Education (> = 18 years, n = 1,421)
None 44 3.1
Primary 517 36.4
Secondary 689 48.5
Superior 171 12.0
Income amount*
None 2,081 78.0
< 650 PEN 458 17.2
> = 650 PEN 83 3.1
Missing 45 1.7
Current economic activity
None (children, students, retired) 1,319 49.5
Farmer 41 1.5
Moto-taxi driver 74 2.8
Housewife 723 27.1
Trader 172 6.4
Laborer (indoor, manual worker) 240 9.0
Others 98 3.7
Occupation as farmer (previous 12 months)
No 2,604 97.6
Yes 63 2.4
Occupation as moto-taxi driver (previous 12 months)
No 2,598 97.4
Yes 69 2.6
Table 1 Baseline characteristics of the study population
(N = 2,667) (Continued)
Bed net use
Never/Sometimes 1,250 46.9
Always 1,402 52.6
Missing 15 0.5
Confirmed P. vivax malaria (previous 12 months)
No 2,360 88.5
Yes (1 episode) 273 10.2
Yes (> = 2 episodes) 34 1.3
*Income expressed in Peruvian nuevos soles (PEN). The official vital minimum
wage in Peru is 650 PEN (approx 230 USD).
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north for about 2 km (maximum width 100 m, depth
30 m) to end into the Chira River.
The winter season is from May to November and the hot
and rainy summer from December to April. This seasonal
pattern is periodically altered by the ENSO phenomenon
[27] with torrential rain and strong winds that can cause
flooding and landslides. In 2010, annual rainfall, average
relative humidity and average temperature were 103 mm,
76% and 24.2°C, respectively [28]. The main vector is
Anopheles albimanus and the vast majority of malaria cases
are due to P. vivax [29]. The main occupations in the area
are informal trade, agriculture and small animal farming.
Data collection
A full census of the study population was carried out in
April 2010, collecting individual data on sociodemographic
(age, gender, education, economic activities, income) as well
as on malaria prevention characteristics. Each house was
identified with a unique code number and georeferenced
using a handheld global positioning system (GPS) device
(Garmin’s GPSMAP 60CSx) that also calculated the closest
distance to the water drain. Each individual was given a
seven-digit unique code number combining the village,
household and individual code.
The cross-sectional survey was carried out in May
2010 and included all residents in the study area. Each
household was visited, and a written informed consent
was sought from each participant. If part of, or the
whole household, was absent at the time of survey, the
study team would return within the next two days to
maximize subject participation. Each participant was ex-
amined for fever and malaria symptoms, and a finger-
prick blood sample was taken for immediate microscopy
(thick and thin blood smears) and later serological and
molecular tests at Institute of Tropical Medicine
Alexander von Humboltd, Lima (ITM-AvH). Filter paper
(Whatman grade 3, Whatman, Springfield Mill, USA)
dried blood samples were individually stored at 4°C with
Table 2 Malaria prevalence (by microscopy and PCR) and seroprevalence
n N % 95% CI
Prevalence by microscopy P. vivax 8 2,667 0.3 [0.2; 0.6]
Parasite density/μl, median [range] 432 [112; 1,529]
Prevalence by PCR P. vivax 25 2,667 0.9 [0.7; 1.4]
P. falciparum 1 2,667 0.04 [0.01; 0.3]
Any species 26 2,667 1 [0.6; 1.4]
Seroprevalence PvMSP119 360 2,653 13.6 [12.2; 15.1]
PfGLURP 259 2,653 9.8 [8.6; 11.1]
Total 567 2,653 21.4 [19.7; 23.1]
Table 3 Association between Plasmodium vivax PCR results and microscopy, serology and symptoms
P. vivax PCR Negative P. vivax PCR Positive
(N = 2642) (N = 25)
n % n % p-value
P. vivax microscopy
Negative 2,642 100 17 68.0 <0.001
Positive 0 0 8 32.0
P. vivax MSP1-19 serology
Negative 2,282 86.8 11 44.0 <0.001
Positive 346 13.2 14 56.0
P. falciparum GLURP serology
Negative 2,369 90.2 22 88.0 0.71
Positive 256 9.8 3 12.0
Fever and/or history of fever (previous 2 days)
No 2,592 98.1 22 88.0 <0.001
Yes 50 1.9 3 12.0
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desiccant until processed at the ITM-AvH. Infected indi-
viduals (presence of Plasmodium trophozoites) were
treated according to the national guidelines.
Additionally, retrospective data on annual malaria inci-
dence by species from 1990 to 2010, registered by the
Office of Epidemiology at Regional Health Direction of
Piura, were obtained from the National Institute of
Statistics and Informatics [7,28]. In Peru, weekly notifi-
cation of confirmed malaria cases (by standard micros-
copy) at health facilities and data aggregation at district
Table 4 Multivariate adjusted analysis for the risk of exposure to Plasmodium vivax using survey logistic regression
Risk factors Positive PvMSP1-19 Unadjusted Adjusted ≈
% 95% CI n N OR 95% CI OR 95% CI
Settlement
PAV 12.7 [10.8; 14.9] 143 1,123 1.0 -
JCM 15.6 [13.1; 18.5] 123 789 1.3 [0.95; 1.7] -
NP 12.7 [10.0; 15.9] 94 741 1.0 [0.7; 1.4] -
House distance to water drain (m)
>250 9.5 [7.8; 11.6] 103 1,080 1.0 1.0
100–250 15.6 [13.6; 17.9] 217 1,391 1.8* [1.3; 2.3] 1.8* [1.4; 2.4]
<100 22.0 [16.2; 29.2] 40 182 2.7* [1.7; 4.1] 2.8* [1.8; 4.4]
Age groups (years)
0.5–5 6.7 [4.7; 9.4] 29 433 1.0 1.0°
6–10 8.9 [6.5; 12.1] 36 404 1.4 [0.8; 2.2]
11–19 13.9 [10.7; 16.7] 68 491 2.2* [1.4; 3.5] 2.1*∞ [1.6; 2.8]
20–39 15.8 [13.4; 18.4] 140 889 2.6* [1.7; 3.9]
> = 40 20.0 [16.5; 24.0] 87 436 3.5* [2.2; 5.4] 3.1* [2.2; 4.4]
Education
None 8.1 [6; 10.8] 39 483 1.0 -
Primary 13.3 [11.3; 15.7] 140 1,199 1.8* [1.2; 2.5] -
Secondary 16.3 [14; 19] 153 829 2.2* [1.5; 3.2] -
Superior 15.1 [10.7; 20.9] 27 141 2.0* [1.2; 3.4] -
Income amount
None 12.6 [11.1; 14.3] 261 2,067 1.0 -
< 650 PEN 17.9 [14.7; 21.7] 82 458 1.5* [1.2; 2] -
> = 650 PEN 14.5 [8.4; 23.8] 12 83 1.3 [0.6; 2.2] -
Occupation as farmer(previous 12 months)
No 13.3 [11.9; 14.8] 344 2,590 1.0 -
Yes 25.4 [16.3; 37.3] 16 63 2.2* [1.3; 3.9] -
Occupation as moto-taxi driver (previous 12 months)
Never/Sometimes 13.4 [12.1; 14.9] 347 2,584 1.0 -
Always 18.8 [11.2; 30.0] 13 69 1.5 [0.8; 2.8] -
Bed net use
No 13.0 [11.1; 15.2] 162 1,244 1.0 -
Yes 14.1 [12.2; 16.2] 196 1,395 1.1 [0.9; 1.4] -
Confirmed P. vivax malaria (previous 12 months)+
No 10.5 [9.3; 12] 247 2,346 1.0 -
Yes (1 episode) 33.3 [27.9; 39.3] 91 273 4.2* [3.2; 5.7] -
Yes (> = 2episodes) 64.7 [46.7; 79.3] 22 34 15.6* [7.3; 33] -
* p < 0.05. + Not considered in the multivariate analysis.
° Baseline category = 0.5–10 years.
∞ Include ages between 11 and 39 years.
≈ A significant interaction (OR = 5.7; 95CI [1.4; 22.7], p = 0.014) was found between age >10 years and distance <100 m.
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and at departmental level are mandatory. Patients pre-
senting with symptoms compatible with malaria at
health facilities are systematically tested by microscopy
and treated following national guidelines.
Laboratory procedures
Microscopy
Thick and thin smears were stained for 10 min with a 10%
Giemsa solution, and parasite density was expressed as the
number of parasites/μl, after counting a total of 200 white
blood cells (WBC) (or 500 WBCs if less than ten parasites/
field), and assuming an average of 6,000 WBCs/μl
according to the national guidelines [30]. Microscopy
examination was performed immediately after sample col-
lection at the Reference Laboratory in Sullana, and later
quality control was done blindly on all positive slides and
10% of randomly chosen negative slides by a senior techni-
cian at ITM-AvH. Any discordant results were reread by a
second senior technician until agreement.
Table 5 Multivariate adjusted analysis for the risk of exposure to Plasmodium falciparum using survey logistic
regression
Risk factors Positive Pf GLURP-19 Unadjusted Adjusted
% 95% CI n N OR 95% CI OR 95% CI
Settlement
PAV 7.4 [5.9; 9.3] 83 1,123 1.0 1.0
JCM 9.6 [7.6; 12.2] 76 789 1.3 [0.9; 1.9] 1.5* [1.02; 2.1]
NP 13.6 [11; 16.5] 100 738 2.0* [1.4; 2.8] 2.2* [1.6; 3.2]
House distance to water drain (m)
>250 10.6 [8.7; 12.8] 114 1,080 1.0 -
100–250 8.7 [7.3; 10.4] 121 1,388 0.8 [0.6; 1.1] -
<100 13.2 [8.7; 19.5] 24 182 1.3 [0.8; 2.2] -
Age groups (years)
0.5–5 3.7 [2.9; 7.4] 16 432 1.0 1.0
6–10 7.4 [3.4; 8.0] 30 404 2.1* [1.1; 3.9] 2.1* [1.1; 3.8]
11–19 12.5 [9.7; 15.9] 61 490 3.7* [2.1; 6.5] 3.2*∞ [1.9; 5.3]
20–39 10.3 [8.4; 12.5] 91 888 3.0* [1.8; 5.0]
> = 40 14.0 [11.0; 17.6] 61 436 4.2* [2.4; 7.4] 4.7* [2.6; 8.3]
Education
None 6.0 [4.2; 8.5] 29 483 1.0 -
Primary 10.0 [8.3; 12] 105 1,051 1.7* [1.1; 2.7] -
Secondary 11.1 [9.2; 13.4] 104 937 2.0* [1.3; 3] -
Superior 11.8 [7.8; 17.6] 21 178 2.1* [1.2; 3.8] -
Income amount
None 9.2 [8; 10.6] 190 2,064 1.0 -
< 650 PEN 11.8 [9.1; 15.1] 54 458 1.3 [0.96; 1.8] -
> = 650 PEN 14.5 [8.4; 23.8] 12 83 1.7 [0.9; 3.1] -
Occupation as farmer (previous 12 months)
No 9.6 [8.4; 10.9] 248 2,587 1.0 -
Yes 17.5 [9.9; 29] 11 63 2.0* [1.03; 3.9] -
Occupation as moto-taxi driver (previous 12 months)
No 9.5 [8.3; 10.8] 245 2,581 1.0 1.0
Yes 20.3 [12.4; 31.4] 14 69 2.4* [1.3; 4.4] 2.1* [1.1; 3.8]
Bed net use
Never/Sometimes 11.3 [9.5; 13.4] 141 1,244 1.0 -
Always 8.5 [7.1; 10.2] 118 1,392 0.7* [0.6; 0.96] -
* p < 0.05.
∞ Included all ages between 11 and 39 years.
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Species-specific polymerase chain reaction (ss-PCR)
Parasite DNA was extracted using the saponin Chelex
100 method [31]. Briefly, filter-paper blood spots
containing approximately 20 μl of blood were cut into
pieces of approximately 5 sq mm, and incubated with
20 μl of 0.05% saponin at room temperature for four
hours. Then, 10 μl of 20% Chelex 100 solution was
added, and the sample was incubated for 10 min at
95°C, followed by a centrifugation at 11,000 g. The
supernatant (DNA) was transferred into a new tube and
stored at −20°C until PCR was performed. The DNA
was amplified by a semi-nested multiplex PCR method
targeting the 18S rDNA region, as described by Rubio et
al [32]. PCR products were analysed in a 2% agarose gel
with a standard 100 bp DNA lader, using ethidium
bromide staining (0.5 μg/ml) and a data image Analyzer
with UV trans-illuminator.
Serology
Plasmodium falciparum glutamate-rich protein (PfGLURP)
and P. vivax merozoite surface protein119 (PvMSP119) anti-
bodies were detected using an ELISA protocol published
elsewhere [33]. Briefly, dried blood filter-paper samples
(5 mm diameter disc/sample) were eluted overnight at 4°C
in 2 ml of PBS-Blotto-Tween. Two hundred μl of the eluate
were added in duplicate to blocked ELISA plates (Plate
Chamaleon, Hydex) coated separately with P. falciparum
GLURP R2 [34] and P. vivax MSP1-19 [35]. Pooled sera
from five P. falciparum- or P. vivax-infected patients, and
from five non-infected control group were diluted at 1:400
in PBS-Blotto, as positive and negative control, respectively.
Goat anti-human IgG (H+ L) peroxidase (Sigma, affinity
purified) diluted to 1: 20,000 in PBS-Tween was used as
conjugate and incubated for one hour before development
of the ELISA using 200 μl ABTS substrate-chromogen so-
lution. Optical densities (ODs) were read at 405 nm, and
corrected OD values were computed by subtracting the
mean OD of the antigen negative control wells from the
mean OD of the corresponding antigen containing wells.
To ensure a standardization of the sample results across
ELISA plates, the percent positivity (PP) of each specimen
was calculated using the OD of the positive control serum
as 100%. Quality control was done blindly at ITM-AvH on
5% of randomly chosen samples. The cut-off for positivity
was generated using a mixture model as previously de-
scribed by Corran et al. [36].
Data management and statistical analysis
Data were double entered, validated and cleaned in Excel
(Microsoft Corp, USA), and data analysis was performed
with Stata v.11 (Stata Corp, College Station, USA) and R
v.2.15 software (R Development Core Team, R Foundation
for Statistical Computing, Austria).
Malaria infection by PCR was defined as an individual
with a positive PCR result, regardless of symptoms. Clinical
malaria was defined as a patient with fever (body
temperature >37.5°C), and/or history of fever in the previ-
ous two days, and positive for malaria by microscopy and/
or PCR. As maternally derived antibodies can be found in
young infants [37], malaria exposure was defined as an indi-
vidual older than six months with a positive ELISA test for
either or both P. falciparum and P. vivax. Descriptive statis-
tics were used to calculate malariometric indices (parasite
and antibody prevalence). Uni- and multivariate adjusted
analyses were performed using survey logistic regression to
determine risk factors for malaria infection (PCR positive)
or malaria exposure (serology positive) adjusting for all po-
tential confounders such as: settlement, gender, age, in-
come, education, occupation during previous year, bed net
use, distance to the water drain, and movements outside
the settlement during previous year. A p-value <0.05 was
considered significant for risk factors to be included in the
multivariate adjusted model. Interactions were systematic-
ally checked for up to order two. All analyses took into ac-
count the survey design characteristics, using settlement as
strata and household as primary sampling unit.
A simple reversible catalytic conversion model
was used to fit the dichotomized serological results,
using maximum likelihood methods as published by
Drakeley et al. [22]. Briefly, this model generates age-
seroprevalence curves, allowing for the estimation of the
force of infection, or seroconversion rate (SCR, λ), and a
seroreversion rate (ρ). Upon visual examination, if age-
seroprevalence data suggest an obvious step at a certain
age (time point), a model allowing for two forces of in-
fection (λ1 and λ2) and related profile likelihood plots
are run to determine the most likely time point for
change in SCR, as previously described by Stewart et al.
[24]. The identified time point is subsequently incorpo-
rated into the catalytic model to fit a seroprevalence
curve with two forces of infection (before and after time
cut-off ) [38], which is then compared -using the likeli-
hood ratio (LR) test (p < 0.05)- with a sero-prevalence
curve with only one force of infection.
Ethical issues
Permission was received from health and local author-
ities after explaining the purpose and procedures of the
survey. Signed, informed consent was obtained prior to
participation by all adults and the parents of all partici-
pating children <18 years. In addition to their parent’s
consent, children ≥ seven years old provided signed in-
formed assent prior to participating. Ethical clearance
was obtained from the Ethics Review Board of the
Universidad Peruana Cayetano Heredia, Lima, Peru
(SIDISI code: 056736).
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Results
A total of 996 households and 4,650 individuals were
identified during the census, and were distributed over
the three study settlements as follows: PAV (433 houses;
2,163 individuals), JCM (312; 1,358) and NP (251; 1,129).
The overall sex ratio was 0.94, and the age distribution
showed that half of the population was <20 years old. A
total 2,733 individuals (58.8%) living in 871 households
(87.4%) were available at the time of the survey and
97.6% (2,667/2,733) of them accepted to participate. Fe-
males (61%) slightly outnumbered males, but the age
distribution was very similar to the one in the total
population. Among adults aged ≥18 years old, 60% had
completed secondary education level. Only about 20% of
the respondents had a regular income, almost all below
the minimum national vital wage. The most commonly
reported occupations were housewife (27.1%), labourer
(9.0%) and trader (6.4%), while preprofessionals (chil-
dren, students) and retired represented half of the par-
ticipants. Very few respondents reported having been
working as farmer (2.4%) or moto-taxi driver (2.6%) in
the past year. More than half (52.6%) of the participants
stated they were regularly sleeping under an untreated
net, and 11.5% had experienced at least one confirmed
P. vivax episode during the previous year (Table 1).
Parasite prevalence determined by microscopy was
0.3% (total eight P. vivax infections) while by PCR it was
estimated at 1% including one P. falciparum and 25 P.
vivax infections (Table 2). Malaria seroprevalence for P.
vivax and P. falciparum was estimated at 13.6 and 9.8%,
respectively, with 9.0% of the total seropositive individ-
uals having antibodies against both antigens. A very
weak correlation between antibody responses (percent
positivity = PP) to the two species were found in individ-
uals older than ten years (r = 0.1, p < 0.001), but not in
younger children (p > 0.1). Most of the P. vivax PCR-
positive cases were submicroscopic (17/25 = 68.0%) and
asymptomatic (22/25 = 88.0%) at the time of the survey
(Table 3). PCR positivity to P. vivax was significantly as-
sociated with the presence of P. vivax parasites (by mi-
croscopy) (p < 0.001) or antibodies (p < 0.001), as well as
with symptoms (p < 0.001). Association between PCR
and sero-positivity to P. falciparum could not be ex-
plored since only one P. falciparum infection was
detected by PCR. This infection was asymptomatic and
submicroscopic, and was found in a 16-year-old girl who
also had antibodies against P. falciparum.
Given the small number of PCR-positive individuals, a
multivariate adjusted risk factor analysis was not carried
out, and the univariate analysis showed that distance to
water drain was significantly associated with the risk of
P. vivax infection (no association could be found with
age, gender, income, education, bed net, or previous
travelling outside the community). Individuals living
at <100 m from the water drain had increased odds of
P. vivax infection than those living farther (≥100 m)
(OR = 3.4, 95% CI [1.3–9.0]).
Distance to water drain, age, education, income, occu-
pation as farmer in the previous year, and history of P.
vivax malaria in the previous year were significantly as-
sociated to P. vivax exposure in the univariate analysis
(Table 4). The multivariate analysis (excluding history of
malaria in the previous year) showed that only age and
distance to water drain remained independently associ-
ated with P. vivax seropositivity. Individuals older than
ten years had increasingly higher odds of P. vivax sero-
positivity compared to younger children (test for trend
p < 0.001), while those living at closer distance to the
water drain had increasingly higher odds of exposure to
P. vivax compared to those living farther than 250 m. A
significant interaction (OR = 5.7; p = 0.014) between age
groups > ten years and distance <100 m was found,
showing that the effect of age (>ten versus ≤ ten years)
was significantly higher in those living closer (<100 m)
to the drain (OR = 11.7; 95 CI [3.0; 45.1]; p < 0.001) com-
pared to those living farther (OR = 2.0; 95 CI [1.5; 2.7],
p < 0.001). Conversely, the effect of distance to water
(<100 m versus ≥100 m) was significant only in the older
age group (OR = 2.4, 95 CI [1.6; 3.7], p < 0.001).
Significant risk factors for P. falciparum exposure
identified in the univariate analysis were the following:
settlement, age, education, prior work as farmer or
moto-taxi driver, and bed net use (Table 5). The
multivariate-adjusted analysis showed that only settle-
ment, age and previous work as moto-taxi driver
remained independently associated with exposure to P.
falciparum (no interaction was found). Individuals living
in JCM (AOR: 1.5, 95% CI [1.02–2.1]) and in NP (AOR:
2.2, 95% CI [1.6–3.2]) were more likely to be exposed to
P. falciparum compared to those living in PAV. In
addition, individuals older than five years had increas-
ingly higher odds (test for trend p < 0.001) of P. falcip-
arum seropositivity compared to younger children, and
those having worked as moto-taxi driver in the previous
year were two times more exposed to P. falciparum
(AOR: 2.1, 95% CI [1.1–3.8]) compared to those who did
not.
Age seroprevalence plots for PvMSP119 and PfGLURP
are shown in Figure 2 (A and B), and confirm previous
results: increasing P. vivax and P. falciparum seropreva-
lence with age. Likelihood ratio (LR) tests supported
models with two SCR (forces of infection) rather than
one SCR for both P. vivax (p = 0.028) and P. falciparum
(p = 0.046), indicating significant changes over time in
the MTI for both species. For PvMSP119, best estimates
indicated a significant four-fold increase in the SCR ap-
proximately four years prior to the survey (year 2006):
post-2006 λ1 = 0.024 (95% CI [0.018–0.032]) and pre-
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2006 λ2 = 0.006 (95% CI [0.002–0.017]). For PfGLURP,
best estimates indicated a 19–fold drop in the SCR ap-
proximately eight years prior to the survey (year 2002):
post-2002 λ1 = 0.022 (95% CI [0.014–0.033]), and pre-
2002 λ2 = 0.431 (95% CI [0.041–4.54]).
The retrospective analysis of 20-year annual malaria
incidence and rainfall from 1990 to 2010 in Piura de-
partment showed that after the El Niño-Southern Oscil-
lation (ENSO) phenomenon in 1997–1998 (Figure 3),
when nearly 50,000 P. falciparum cases were recorded
(1998), P. falciparum incidence dropped and stabilized
around 4,000–5,000 cases annually in 2000–2001. This
was followed by a steady decrease, and since 2006, au-
tochthonous P. falciparum reported cases have become
scarce (six and three reported cases in 2006 and 2008,
respectively; and no cases in 2007, 2009 and 2010). Simi-
larly to P. falciparum, P. vivax incidence decreased grad-
ually after the ENSO (around 23,000 cases in 1998)
reaching very low levels during the four-year period of
intense droughts, with only 700, 315, 168, and 606
reported cases, respectively from 2004 to 2007. However,
since then, P. vivax cases have increased with 4,185,
2,735 and 2,153 cases in 2008, 2009 and 2010, respect-
ively. During the same period, annual rainfall in Piura
dramatically dropped from 1998 (1,687 mm) to mini-
mum values (between 14.3 and 59.4 mm) during the
drought period, but subsequently increased since 2008
(193.5 mm in 2008).
Figure 2 Malaria seroprevalence curves. A: Seroprevalence curve for Plasmodium vivax. B: Seroprevalence curve for Plasmodium falciparum.
Points represent observed data points, whilst the blue lines represent the maximum likelihood model and 95% confidence intervals. Estimated
force of infection (λ) is plotted on the graphs. Two forces infection are plotted by likelihood ratio tests indicating change at a certain point in
calendar time.
Figure 3 Evolution of the annual malaria incidence, and rainfall, in Piura department: 1990–2010. Information on annual malaria cases,
registered by Regional Health Direction of Piura, was obtained from the National Institute of Statistics and Informatics [27]. Numbers in the
timeline point out important events that influenced malaria incidence: 1) moderate ENSO phenomenon (1991–1992), 2) first reports of
chloroquine (CQ) failure for Plasmodium falciparum (since 1994), 3) very strong ENSO phenomenon (1997–1998), 4) confirmed CQ resistance for
Plasmodium falciparum (1999), 5) ACT implementation (2001–2003), 6) intense droughts (2004–2007).
Rosas-Aguirre et al. Malaria Journal 2013, 12:339 Page 9 of 13
http://www.malariajournal.com/content/12/1/339
Discussion
The combination of molecular and serological tools, in
addition to standard microscopy, allowed for an in-
depth characterization of the current malaria transmis-
sion pattern as well as recent changes in species-specific
MTI in this peri-urban area of the Peruvian northern
coast. Most of the malaria infections were submicro-
scopic (70%), as well as asymptomatic (89%) despite the
low level of transmission. Though P. vivax was predom-
inant, species-specific seroprevalence showed that ex-
posure to P. falciparum still occurs in the study area.
Interestingly, over the past ten years, both species expe-
rienced significant but opposite changes in MTI: while
P. falciparum MTI dropped after 2002, the one of P.
vivax significantly increased after 2006.
Despite having been conducted at the end of rainy sea-
son, when the health information system usually records
the highest malaria incidence [7], few malaria-infected
individuals were identified and most of them had not
had malaria-related symptoms within the two days prior
to the survey. These results are in line with findings
from other areas in the northern coast [39] and the
Peruvian Amazon region [40,41] and support the hy-
pothesis that this asymptomatic and submicroscopic res-
ervoir of infections contributes to malaria transmission
[42].
In areas of low malaria transmission with seasonal pat-
terns affected by climatic conditions, such as the Peru-
vian northern coast region, parasitological indicators
determined by microscopy or PCR can be insensitive. In
these areas, serological measures can be used as a proxy
for malaria transmission intensity [20,23,25,36]. Indeed,
seroprevalence reflects the cumulative exposure to mal-
aria and, since antibodies persist longer in the blood
than parasites, it is more sensitive and less affected by
seasonality or unstable transmission [22,23,43]. Though
it may be limited in detecting discrete seasonal varia-
tions in transmission, it is a good indicator of long-term
transmission potential [22,24].
Even though P. falciparum reported cases in Piura de-
partment have been extremely rare in the past five years,
P. vivax and P. falciparum seroprevalence indicated on-
going exposure to both species. The low PfGLURP sero-
positivity in young children and the only one P.
falciparum case detected by PCR suggest that a residual
P. falciparum transmission is still present in the study
area. This residual transmission may be due to asymp-
tomatic P. falciparum infections that remain undetected,
unless a population-wide survey (such as the present
study) is carried out. However, the implementation of
mass screening as a public health strategy in low trans-
mission settings remains a matter of debate [18,40,41],
as the cost-effectiveness of such an intervention remains
difficult to establish. The role of asymptomatic infections
in maintaining malaria transmission as well as the im-
pact of mass screening and treatment should be further
evaluated through modelling techniques [44].
One might argue that an alternative explanation for
the observed P. falciparum seropositivity could be the
presence of antibodies cross-reacting with P. vivax or
other infectious agents’ antigens. Limited information is
available about the cross-reactivity between P. falcip-
arum and P. vivax antigens [35,45], and this has not
been reported for PfGLURP. In addition, the lack of as-
sociation between confirmed P. vivax infections by PCR
and PfGLURP seropositivity, and the absence of correl-
ation between antibody responses to the two species
suggest that cross-reactivity is probably minimal. A few
studies have suggested the cross-reactive potential of
PfGLURP with Schistosoma haematobium [46], which is
unlikely in the study area since the latter has not been
reported in Piura.
Serologic markers can also be used to determine risk
factors for malaria. This is particularly important in low
endemicity areas as the one reported here, where the
low malaria prevalence jeopardizes the risk factor ana-
lysis. In the study area, age was the only independent
risk factor that was associated to both species. The age-
dependent PvMSP119 and PfGLURP seropositivity indi-
cates cumulative P. vivax and P. falciparum exposure
with increasing age. As antibody responses will persist
for prolonged periods, the rate of acquisition in young
age groups can be used to determine current malaria
transmission intensity [22-25] as well as to identify re-
cent changes in MTI.
The higher seroprevalence in individuals with several
P. vivax malaria episodes also confirmed that PvMSP119
antibody detection measures cumulative exposure. How-
ever, the history of P. vivax malaria in the past year was
not included in the multivariate risk factor analysis for
P. vivax exposure, since it is not a risk factor for P. vivax
infections per se but rather a consequence of previous
exposure to a given risk factor. Plasmodium vivax infec-
tions are on the pathway between risk factors and the
presence of P. vivax antibodies.
Differences in the risk factors for P. vivax and P. fal-
ciparum seropositivity reflect the heterogeneity of mal-
aria transmission intensity between species. Age and
distance to the water drain were the only two independ-
ent risk factors significantly associated with P. vivax ex-
posure. As mentioned above, the effect of age on
seroprevalence usually reflects the cumulative exposure
to malaria infections occurring with age rather than a
higher risk of exposure in adults as compared to chil-
dren. However, the significant interaction found between
age and house distance to the drain, beside the cumula-
tive effect of age on seroprevalence, indicates a signifi-
cant lower exposure in children aged < ten years. Indeed,
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the effect of distance (<100 m versus ≥100 m) on P.
vivax seropositivity was only significant in adults, indi-
cating that children living close to the drain were not ex-
posed any more to infectious bites compared to children
living farther. Water accumulation in the drain provides
breeding habitats for Anopheles malaria vectors after
rains [30,39], resulting in a higher risk of exposure to in-
fectious vectors for people living close to the drain. This
is also supported by the results of univariate analysis for
the risk of P. vivax infection. However, since adults are
more likely to have outdoor evening activities, this could
explain why children below ten, were no more at risk of
malaria while living close to the drain.
Besides age, settlement and prior work as moto-taxi
driver in the previous year, there were two additional inde-
pendent risk factors for P. falciparum seropositivity. Histor-
ically, the three study settlements were important foci of P.
falciparum transmission during the epidemic of 1998 and
the early 2000s [47,48]. Therefore, higher seroprevalence in
JCM and NP, compared to PAV again suggest differential
reduction rates in MTI between villages (heterogeneity).
Occupational activities outside settlements (as moto-taxi
driver) that were associated with increased P. falciparum
exposure support the hypothesis that transmission occurs
not only in the immediate house environment as previously
described by Guthmann et al. [29], but outside the commu-
nity as well. Moto-taxi drivers in the study area usually
work in evening times, when exposure to An. albimanus
bites increases. Occupational risk for malaria has also been
found in the Peruvian Amazon Region, where malaria mor-
bidity has been clearly associated with forest-related activ-
ities such as farming, land clearing and wood extraction
[49,50].
The catalytic model used to generate PfGLURP sero-
prevalence curves suggested that a significant decline in
P. falciparum transmission occurred in the study area
approximately eight years before the current study
(around 2002). This supports the idea that the wide scale
implementation of ACT since 2001 has significantly con-
tributed to the reduction of P. falciparum MTI. Indeed,
following the 1998 epidemic and the subsequent intensi-
fied control interventions implemented [9], P. falcip-
arum incidence returned to the pre-epidemic levels
(1997) by 2000–2001 (around 5,000 cases), and since
2002 it steadily decreased to reach almost undetected
levels from 2007 onwards (Figure 3). In addition, the ab-
sence of P. falciparum surge after the drought period in
2007, as observed with P. vivax, advocates for the add-
itional significant effect of the ACT deployment on P
falciparum MTI in the northern coast region [8].
Since the end of the drought period and the resuming
of the rains, P. vivax incidence substantially increased
[7] (Figure 3) which is concordant with the fitted results
from the model, i.e., significant increase in P. vivax MTI
after 2006. Plasmodium vivax transmission in this area
seems to be more sensitive than P. falciparum to
changes in climatological and environmental conditions,
especially since the implementation of ACT. The recent
changes in species specific MTIs are also in line with the
results of the multivariate risk factor analysis. While
children under-five were significantly at lower risk of P.
falciparum exposure compared to older children age 6-
10, this was not the case for the P. vivax exposure where
the under five were at similar risk of exposure compared
to the 6-10 years old.
The number of antigens used in the two serological
tests could be a limitation of the study. Due to the
degree of sequence variability, it is recommended to
use multiple antigens for each species in order to
optimize the sensitivity of the antibody detection and
to improve the identification of changes in malaria
transmission over time in low transmission settings
[20,38]. However, the observation that the antigens
used in the study are relatively conserved [51] com-
bined with results from recent studies performed in
Cambodia, Vietnam and Peru suggests that PfGLURP
and PvMSP119 are highly suitable for the detection of
antibodies against P. falciparum and P. vivax, respec-
tively [33,52]. Multiplexing the serological tests as
well as standardizing the antigens used is of crucial
importance for monitoring elimination efforts and
comparing trends across countries and regions.
Conclusions
Monitoring MTI in areas of low endemicity and seasonal
patterns, such as the north-western coast of Peru, poses a
major challenge to national malaria control programmes.
In this setting, molecular tools confirmed the current mal-
aria transmission pattern characterized by low parasite
rates, mainly due to P. vivax with a majority of asymptom-
atic and sub-microscopic infections. Additionally, sero-
logical markers reflected exposure to malaria and allowed
for species-specific risk factor analysis, as well as showing
recent changes in respective MTIs. In conclusion, the com-
bination of both serological and molecular tools improved
detection sensitivity, and provided new insights into recent
changes in transmission intensity for both species. This in-
valuable information can help decision-makers to adjust
malaria control strategies in order to maintain current
achievements, avoid outbreaks, and possibly move towards
the elimination of malaria.
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